| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.110 | 32.637 | 8.523 | 4.673 | 6.952 | 5.370 | 4.611 | 6.847 | 2.363 | - |
| Total Income - EUR | 11.110 | 32.637 | 8.523 | 4.673 | 6.952 | 5.370 | 4.611 | 6.853 | 2.363 | - |
| Total Expenses - EUR | 9.060 | 25.710 | 5.597 | 59 | 60 | 56 | 55 | 78 | 70 | - |
| Gross Profit/Loss - EUR | 2.049 | 6.927 | 2.926 | 4.614 | 6.892 | 5.314 | 4.555 | 6.775 | 2.293 | - |
| Net Profit/Loss - EUR | 1.716 | 6.274 | 2.670 | 4.474 | 6.683 | 5.160 | 4.338 | 6.570 | 1.921 | - |
| Employees | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Ropamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 191 | 189 | 186 | 183 | 179 | 176 | 172 | 172 | 172 | - |
| Current Assets | 16.775 | 11.104 | 10.525 | 14.803 | 21.287 | 26.016 | 29.744 | 10.756 | 3.466 | - |
| Inventories | 15.628 | 5.110 | 208 | 204 | 200 | 196 | 192 | 192 | 192 | - |
| Receivables | 0 | 3.853 | 261 | 256 | 251 | 246 | 241 | 8.604 | 2.297 | - |
| Cash | 1.147 | 2.140 | 10.057 | 14.343 | 20.836 | 25.573 | 29.312 | 1.959 | 978 | - |
| Shareholders Funds | 1.761 | 8.018 | 10.552 | 14.832 | 21.229 | 25.986 | 29.748 | 9.259 | 1.962 | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 15.205 | 3.275 | 159 | 153 | 237 | 205 | 168 | 1.669 | 1.676 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4719 - 4719" | |||||||||
| CAEN Financial Year |
4719
|
|||||||||
Comments - Ropamed Srl